Khmelnytskyi Regional Hospital /ID# 230680

Khmelnytskyi 29000

0 studies enrolling now · 1 studies all time

What they study most

Rheumatoid Arthritis (RA)

Studies at this site

• Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA) — Stopped early